Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Binocrit
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Binocrit 1,000units/0.5ml inj pre-filled syringes
0901030D0BCAAAH
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 10,000units/1ml inj pre-filled syringes
0901030D0BCAHAL
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 2,000units/1ml inj pre-filled syringes
0901030D0BCABAW
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 20,000units/0.5ml inj pre-filled syringes
0901030D0BCAIAT
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 3,000units/0.3ml inj pre-filled syringes
0901030D0BCACAJ
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 30,000units/0.75ml inj pre-filled syringes
0901030D0BCAJAV
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 4,000units/0.4ml inj pre-filled syringes
0901030D0BCADAK
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 40,000units/1ml inj pre-filled syringes
0901030D0BCAKAU
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 5,000units/0.5ml inj pre-filled syringes
0901030D0BCAEAM
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 6,000units/0.6ml inj pre-filled syringes
0901030D0BCAFAN
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
|
Binocrit 8,000units/0.8ml inj pre-filled syringes
0901030D0BCAGAQ
|
Binocrit | Epoetin alfa | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.